First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Lancet
; 389(10083): 2031-2040, 2017 May 20.
Article
en En
| MEDLINE
| ID: mdl-28342637
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Prednisolona
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Pénfigo
/
Rituximab
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Lancet
Año:
2017
Tipo del documento:
Article